VELOCIHUM Trademark

Trademark Overview


On Friday, January 4, 2019, a trademark application was filed for VELOCIHUM with the United States Patent and Trademark Office. The USPTO has given the VELOCIHUM trademark a serial number of 88250361. The federal status of this trademark filing is REGISTERED as of Tuesday, December 17, 2019. This trademark is owned by Regeneron Pharmaceuticals, Inc.. The VELOCIHUM trademark is filed in the Natural Agricultural Products category with the following description:

Live animals; live, genetically altered animals, namely, rodents genetically altered to allow for enhanced development of human immune cells in vivo, as well as to allow for the enhanced engraftment of human tissue
velocihum

General Information


Serial Number88250361
Word MarkVELOCIHUM
Filing DateFriday, January 4, 2019
Status700 - REGISTERED
Status DateTuesday, December 17, 2019
Registration Number5939837
Registration DateTuesday, December 17, 2019
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 7, 2019

Trademark Statements


Pseudo MarkVELOCI HUM
Goods and ServicesLive animals; live, genetically altered animals, namely, rodents genetically altered to allow for enhanced development of human immune cells in vivo, as well as to allow for the enhanced engraftment of human tissue

Classification Information


International Class031 - Agricultural, horticultural and forestry products and grains not included in other classes; live animals; fresh fruits and vegetables; seeds, natural plants and flowers; foodstuffs for animals; malt.
US Class Codes001, 046
Class Status Code6 - Active
Class Status DateSaturday, January 26, 2019
Primary Code031
First Use Anywhere DateTuesday, October 8, 2019
First Use In Commerce DateTuesday, October 8, 2019

Trademark Owner History


Party NameRegeneron Pharmaceuticals, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressTarrytown, NY 10591

Party NameRegeneron Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressTarrytown, NY 10591

Party NameRegeneron Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressTarrytown, NY 10591

Trademark Events


Event DateEvent Description
Saturday, January 26, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, January 8, 2019NEW APPLICATION ENTERED
Tuesday, March 26, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, May 7, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Thursday, March 21, 2019ASSIGNED TO EXAMINER
Wednesday, April 17, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, May 7, 2019PUBLISHED FOR OPPOSITION
Tuesday, July 2, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, October 25, 2019USE AMENDMENT FILED
Friday, October 25, 2019TEAS STATEMENT OF USE RECEIVED
Friday, November 8, 2019CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, November 8, 2019STATEMENT OF USE PROCESSING COMPLETE
Friday, November 8, 2019ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Saturday, November 9, 2019NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Thursday, July 14, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, July 14, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, July 14, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, December 17, 2024COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, December 17, 2019REGISTERED-PRINCIPAL REGISTER
Monday, June 30, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, June 30, 2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, June 30, 2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, June 30, 2025APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, June 30, 2025TEAS CHANGE OF OWNER ADDRESS RECEIVED